JS

John Sajil

Director Director DIN 08937710
DIN 08937710 First appointment Oct 2020 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 2 historical roles
Total affiliations 2 Since Oct 2020
Shareholding value Locked Premium profile

About John Sajil

Data last updated:

John Sajil has 5 years in corporate governance. Formerly with 2 companies, such as Mednext Pathlabs Llp and Medimpact Medical Llp. Engaged in General Business. Contributes to corporate operations.

DIN 08937710
Primary Designation Director
First Appointment 28 Oct 2020
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Designated Partner10 Mar 20212021Active
Designated Partner28 Oct 20202016Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mednext Pathlabs Llp
Medimpact Medical Llp
Premium access

Shareholding and investment profile for John Sajil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about John Sajil

John Sajil has 5 years in corporate governance. Formerly with 2 companies, such as Mednext Pathlabs Llp and Medimpact Medical Llp. Engaged in General Business. Contributes to corporate operations.

John Sajil is associated with 0 companies as a director.

John Sajil has expertise in General Business.

John Sajil has 5 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available